Literature DB >> 28261993

Carcinoma ex pleomorphic adenoma: A diagnostic challenge on cytology.

Kanika Singh1, Charu Agarwal1, Mukta Pujani1, Pragya Verma1, Varsha Chauhan1.   

Abstract

Carcinoma ex pleomorphic adenoma (Ca ex PA) is a malignant neoplasm arising from primary or recurrent benign pleomorphic adenoma. It is rare with an annual incidence rate of 0.17 tumors per million. Histopathology remains the gold standard for the diagnosis of Ca ex PA, with only a handful of cases reported on cytology. In our case a 66-year-old male presented with the right parotid mass for 5 years rapidly increasing for the last 3 months. Fine needle aspiration cytology (FNAC) smears showed malignant tumor cells in clusters along with benign myoepithelial cells in chondromyxoid background. Histopathologically, highly pleomorphic malignant epithelial cells in sheets along with foci of comedonecrosis and areas corresponding to benign pleomorphic adenoma were observed on careful scrutiny. Immunohistochemistry revealed positivity for cytokeratin (CK 7) and gross cystic disease fluid protein 15 (GCDFP-15) while CK5/6 and high molecular weight CK (34 βE12) were negative in the malignant tumor cells. So, the final impression was Ca ex PA with salivary duct carcinoma as malignant component. We hereby report this case to highlight the significance of FNAC in the diagnosis of Ca ex PA which can be easily missed on cytopathology. However, it is important to corroborate the cytological findings with clinical suspicion of malignancy as well as radiology. Diagn. Cytopathol. 2017;45:651-654.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  carcinoma ex pleomorphic adenoma; malignant transformation; parotid; salivary duct carcinoma

Mesh:

Substances:

Year:  2017        PMID: 28261993     DOI: 10.1002/dc.23704

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  1 in total

1.  Increased MIB-1 expression in salivary gland pleomorphic adenoma that recurs and undergoes malignant transformation.

Authors:  Timo Atula; Jaana Hagström; Anttoni Markkanen; Katri Aro; Anna Ray Laury; Antti A Mäkitie; Caj Haglund
Journal:  Sci Rep       Date:  2022-05-30       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.